John M. Gregory is a former CEO of King Pharmaceuticals, Inc. and resides in

Bristol, Tennessee Bristol is a city in the State of Tennessee. Located in Sullivan County, its population was 26,702 at the 2010 census. It is the twin city of Bristol, Virginia, which lies directly across the state line between Tennessee and Virginia. The ...

. In addition to founding King Pharmaceuticals in 1993, Gregory has founded several other notable business ventures including SJ Strategic Investments (a privately held investment firm) and Leitner Pharmaceuticals. Gregory has also made major investment outside of the pharmaceutical industry, such as his investments within the privately held

United Coal Company United Coal Company (UCC), a coal mining company headquartered in Blountville, Tennessee, is a producer of high grade metallurgical coals. It has operations in Virginia, West Virginia, Kentucky, and Tennessee. History Foundation In 1970, Jim M ...

located in southwest

Virginia Virginia, officially the Commonwealth of Virginia, is a state in the Mid-Atlantic and Southeastern regions of the United States, between the Atlantic Coast and the Appalachian Mountains. The geography and climate of the Commonwealth ar ...

and

Adams Golf Adams Golf, Inc. was an American sports equipment manufacturing company based in Plano, Texas, focused on the golf equipment market. The company produced golf equipment (more specifically clubs). In 2012 it was acquired by TaylorMade (owned by Adi ...

with U.S. corporate offices in

Texas Texas (, ; Spanish language, Spanish: ''Texas'', ''Tejas'') is a state in the South Central United States, South Central region of the United States. At 268,596 square miles (695,662 km2), and with more than 29.1 million residents in 2 ...

. Most recently, Gregory, along with other family members, began Gregory Pharmaceutical Holdings Inc. which include pharmaceutical contract manufacturing company, UPM Pharmaceuticals, and NFI Consumer Products which includes the Blue-Emu brand of products.

King Pharmaceuticals, Inc. activities

On October 29, 1991, the U.S. Patent and Trademark Office awarded the German pharmaceuticals company Hoechst AG a patent entitled ''Hypotensive agents; e.g. ramipril''. Altace is the trademarked name for

ramipril Ramipril, sold under the brand name Altace among others, is an ACE inhibitor type medication used to treat high blood pressure, heart failure, and diabetic kidney disease. It can also be used as a preventative medication in patients over 55 year ...

. Hoechst merged with Marion Merrill Dow of Kansas City, Missouri in 1995, forming the Hoechst U.S. pharmaceutical subsidiary Hoechst Marion Roussel (HMR). Altace was bringing in under $90 million in U.S. revenues for HMR and Hoechst had stopped promoting Altace within the United States.,"Faith Healers: The born-again Gregory brothers worked a financial miracle from cast-off drug brands"
Forbes. Zina Moukheiber. October 28, 2002. and

King Pharmaceuticals King Pharmaceuticals, is a pharmaceutical company, a wholly owned subsidiary of Pfizer based in Bristol, Tennessee. Before being acquired by Pfizer, it was the world's 39th largest pharmaceutical company. On October 12, 2010, King was acquired by ...

President Jefferson "Jeff" Gregory also began negotiations in 1995 with Hoechst to acquire U.S. distribution rights to Altace. The King Pharmaceuticals wholly owned subsidiary Monarch Pharmaceuticals, Inc. (another brother of John Gregory – Joseph Gregory – was then the president of Monarch Pharmaceuticals) acquired ownership of the U.S. distribution and marketing rights to Altace and other Hoescht products from Hoescht AG subsidiary Hoechst Marion Roussel of Kansas City, Missouri on December 18, 1998, following a January 1999 merger a few weeks later with

Rhône-Poulenc Rhône-Poulenc () was a French chemical and pharmaceutical company founded in 1928. In 1999 it merged with Hoechst AG to form Aventis. As of 2015, the pharmaceutical operations of Rhône-Poulenc are part of Sanofi and the chemicals divisions ar ...

, Hoechst assumed the new corporate identity of

Aventis Sanofi S.A. is a French multinational pharmaceutical and healthcare company headquartered in Paris, France. Originally, the corporation was established in 1973 and merged with Synthélabo in 1999 to form Sanofi-Synthélabo. In 2004, Sanofi-Syn ...

). In 2001, ''

Forbes ''Forbes'' () is an American business magazine owned by Integrated Whale Media Investments and the Forbes family. Published eight times a year, it features articles on finance, industry, investing, and marketing topics. ''Forbes'' also re ...

'' magazine ranked John Gregory among the 400 richest Americans. The bulk of Gregory's personal fortune was due in large part due to the ability of King Pharmaceuticals, Inc. to reintroduce the Hoechst branded prescription drug Altace back into the U.S. market under the King Pharmaceuticals, Inc. subsidiary Monarch Pharmaceuticals brand following the 1998 U.S. marketing and distribution agreement between KingPharmaceuticals/Monarch and Hoechst/HMR.

References

External links

Funding Universe. King Pharmaceuticals, Inc.Gregory Pharmaceutical Holdings, Inc.NFI Consumer Products
{{DEFAULTSORT:Gregory, John M. Businesspeople in the pharmaceutical industry Businesspeople from Tennessee Living people Year of birth missing (living people)